Inspire Medical Systems (INSP) Net Margin (2017 - 2026)

Inspire Medical Systems has disclosed Net Margin across 10 years of filings, most recently posting 5.52% for Q1 2026.

• Net Margin for Q1 2026 came in at 5.52%, down 701.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 14.32% (up 641.0% YoY), and the FY2025 annual result was 15.95%, up 928.0% from the prior year.
• Net Margin came in at 5.52% for Q1 2026 at Inspire Medical Systems, down from 50.56% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 50.56% in Q4 2025 to a low of 24.06% in Q1 2022.
• The 5-year median for Net Margin is 1.65% (2025), against an average of 0.06%.
• Across the five-year window, Net Margin surged 3587 bps in 2025 and tumbled 701 bps in 2026, its largest moves.
• Inspire Medical Systems' Net Margin stood at 2.28% in 2022, then jumped by 236 bps to 7.67% in 2023, then soared by 92 bps to 14.69% in 2024, then surged by 244 bps to 50.56% in 2025, then sank by 111 bps to 5.52% in 2026.
• The last three Net Margin figures came in at 5.52% (Q1 2026), 50.56% (Q4 2025), and 4.42% (Q3 2025), per Business Quant data.